Bruno Occhipinti

Bruno Occhipinti serves as the Chief Executive Officer and Chief Commercial Officer at Qritive since June 2022, where the focus is on expanding AI-powered solutions for pathology. Previously, from May 2021 to May 2022, Occhipinti was the General Manager at AICS, leading a team of over 20 in an AI-for-Healthcare initiative, securing partnerships with large public hospitals, and co-developing AI-assisted solutions. Prior experience includes founding CrestaLab, where the emphasis was on building health ecosystems for equitable care, and significant roles at Philips and Samsung Electronics, contributing to strategic growth in health technology and renewable energy sectors, respectively. Occhipinti holds an MBA from The Wharton School and advanced degrees from the University of Pennsylvania and other esteemed institutions.